Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma is a paper indexed in PICO Portal from OpenAlex.
How many citations does Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma have?
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma has 224 citations in the OpenAlex counts PICO Portal stores.
When was Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma published?
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma has 2017 year in the PICO Portal index.
What is the open-access status of Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma?
Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma has bronze oa status in the PICO Portal index.
What is the DOI of Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma?
The DOI for Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma is on the source record.
What is the PMID of Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma?
The PMID for Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma is on the source record.
What is the OpenAlex record for Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma?
The OpenAlex for Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma is on the source record.